Literature DB >> 25567458

L-Arginine and vascular diseases: lights and pitfalls!

Rocco Salvatore Calabrò1, Giuseppe Gervasi, Placido Bramanti.   

Abstract

L-Arginine, a semi-essential cationic amino acid involved in multiple areas of human physiology and metabolism, is a precursor of nitric oxide, and, recently, it has been found to crucially influence endothelial function. Arginine appears to be safe and effective therapy for many health conditions, particularly vascular diseases responsive to modulation of endothelial-derived relaxing factor including intermittent claudication, angina pectoris and erectile dysfunction. However, L-arginine metabolism is still not fully understood, highlighting a complex implication for its pharmacological use in clinical practice. In this review, we want to point out the lights and pitfalls of L-arginine as potential therapeutic option in vascular disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25567458

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  2 in total

1.  Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium.

Authors:  Enrique Guzmán-Gutiérrez; Axel Armella; Fernando Toledo; Fabián Pardo; Andrea Leiva; Luis Sobrevia
Journal:  Purinergic Signal       Date:  2015-12-28       Impact factor: 3.765

2.  Arginine dimethylation products in pediatric patients with chronic kidney disease.

Authors:  Akram E El-Sadek; Eman G Behery; Ahmed A Azab; Naglaa M Kamal; Mostafa A Salama; Waleed E Abdulghany; Enas A A Abdallah
Journal:  Ann Med Surg (Lond)       Date:  2016-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.